LISAvienna: The March edition of our e-newsletter is available now
We are happy to share a selection of recent news items with you, for example from Blue Sky Immunotherapies, Hookipa Pharma, Semperit, TAmiRNA, Apeiron Biologics, Phenaris, Medizinische Universität Wien, Eucodis Bioscience, Lithoz, BOKU, Austrian BioImaging, Valneva, Health Hub Vienna, Novartis, Image Biopsy Lab, F4 Pharma, a-head bio, bit.bio.discovery, CeMM, Usepat and IST cube.
What else to expect?
Update on funding opportunities such as the Vienna Business Agency’s second Innovate4Vienna call, Horizon Europe and support schemes for the green tech community including the Austria Wirtschaftsservice’s Green Seedfinancing and Innovation Protection Programs
The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.
As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.